Review
Open Access
A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes
Mohammad Alkhalil, Michał Kuzemczak, Alan Bell, Sol Stern, Michelle Welsford, Warren J Cantor and Shaun G Goodman
CMAJ February 14, 2022 194 (6) E205-E215; DOI: https://doi.org/10.1503/cmaj.202863
Mohammad Alkhalil
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Michał Kuzemczak
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Alan Bell
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Sol Stern
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Michelle Welsford
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Warren J Cantor
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.
Shaun G Goodman
Division of Cardiology (Alkhalil, Kuzemczak), Toronto General Hospital, Toronto, Ont.; Cardiothroacic Centre, Freeman Hospital (Alkhalil); Translational and Clinical Research Institute (Alkhalil), Newcastle University, Newcastle upon Tyne, UK; Division of Emergency Medicine (Kuzemczak), Poznan University of Medical Sciences, Poznań, Poland; Department of Interventional Cardiology (Kuzemczak), Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Department of Family and Community Medicine (Bell), University of Toronto, Toronto, Ont.; Argus Medical Centre Family Health Organization (Stern), Oakville, Ont.; Division of Emergency Medicine (Welsford), McMaster University, Hamilton, Ont.; Division of Cardiology (Cantor), University of Toronto and Southlake Regional Health Centre; Division of Cardiology (Goodman), St. Michael’s Hospital, Department of Medicine, University of Toronto, Toronto, Ont.

Data supplements
Earn CPD Credits
This article is eligible for 0.5 Mainpro+ credits.
Did you read this article?
Note: The YES link above may not work in certain versions of Internet Explorer 8. If you are having difficulties with this link, please try another browser.
Related Articles
- Alkhalil, M., Kuzemczak, M., Bell, A., Stern, S., Welsford, M., Cantor, W. J., & Goodman, S. G. (2022). Approche pratique à la prescription des antiplaquettaires chez les patients atteints de syndromes coronariens. CMAJ, 194(17), E620-E631. Accessed May 29, 2023. https://doi.org/10.1503/cmaj.202863-f.
In this issue
Article extras
Article tools
Respond to this article
A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes
Mohammad Alkhalil, Michał Kuzemczak, Alan Bell, Sol Stern, Michelle Welsford, Warren J Cantor, Shaun G Goodman
CMAJ Feb 2022, 194 (6) E205-E215; DOI: 10.1503/cmaj.202863
Jump to section
- Article
- What are the options for oral antiplatelet therapy?
- How long should dual antiplatelet therapy be continued?
- How is bleeding risk assessed and managed?
- Can treatment with acetylsalicylic acid be stopped early?
- What are the indications for dual antiplatelet therapy in patients with atrial fibrillation?
- How should antiplatelet agents be switched?
- Conclusion
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.